After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Pacira BioSciences Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Pacira BioSciences Inc is $975.64M. A total of 1.18 million shares were traded on the day, compared to an average of 686.02K shares.
In the most recent transaction, SLONIN JONATHAN sold 879 shares of PCRX for 18.40 per share on Jan 06 ’25. After the transaction, the Chief Medical Officer now owns 93,444 company shares. In a previous transaction on Jan 06 ’25, SLONIN JONATHAN bought 879 shares at 18.40 per share.
Among the insiders who sold shares, GAUGLER DARYL disposed of 500 shares on Dec 13 ’24 at a per-share price of $19.76. This resulted in the Chief Operating Officer holding 115,200 shares of PCRX after the transaction. In another insider transaction, GAUGLER DARYL bought 500 shares at $19.76 per share on Dec 13 ’24.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, PCRX has a high of $34.01 and a low of $11.16.
As of this writing, PCRX has an earnings estimate of $0.8 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of $0.91 per share and a lower estimate of $0.62.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PCRX’s latest balance sheet shows that the firm has $656.41M in Cash & Short Term Investments as of fiscal 2021. There were $1.13B in debt and $521.12M in liabilities at the time. Its Book Value Per Share was $16.24, while its Total Shareholder’s Equity was $730.41M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PCRX is Buy with a score of 3.13.
